Appeal 2006-3252
Application 09/536,728
1 The most relevant compound described in the Stähle patent is a
2 2-(substituted phenyl-imino)-imidazolidine having the formula set out at
3 col. 1:30-35 where R is 2-chloro-4-methyl-5-amino phenyl. Col. 1:38. The
4 compound has the structural formula:
5
H
H Cl
N
H3C N
N
N H H
6 H H
7
8 Formula 7
9
10 York
11 York relates to compounds said to be suitable for use in the treatment
12 of glaucoma and ocular hypertension. Col. 1:5-7.
13 The York compounds are broadly described as including compounds
14 having the following structure.
H
R1
N
R4 N
N
15 R3 R2 H
16 Formula 8
16
Page: Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next
Last modified: September 9, 2013